Apotex Articles
FTC files Amicus Brief, saying improper use of restricted drug distribution programs may impede generic competition
13 March 2013
Nuvo Research in patent settlement over Pennsaid
29 January 2013
Mixed US court ruling on Merck & Co's Nasonex patent
19 June 2012
FDA approves first generics of Roche osteo drug Boniva
20 March 2012
Sanofi fourth-quarter in line with forecasts; collects damages
8 February 2012
Novartis wins in Apotex patent case; gout drug ACZ885 reduced risk of new attacks by up to 68% vs steroid
26 May 2011
GlaxoSmithKline gains EU appro for epilepsy drug Trobalt; Lovaza patent accord; gets $3.5M from Abbott
31 March 2011
US Appeal Court backs preliminary injunction against Apotex over AstraZeneca’s Pulmicort Respules; rejects Eli Lilly’s Gemzar appeal
3 November 2010
Sanofi facing generic Taxotere competition in USA; first biosimilar cleared in Australia
30 September 2010
Allergan wins in Brimonidine patent infringement case
26 October 2009
Bristol-Myers Squibb says USPTO to review Plavix patent
20 August 2009
Court grants AstraZeneca temp injunction against Apotex
17 April 2009
B-MS exec pleads guilty to anti-trust dealings
7 April 2009
B-MS to pay $2.1M settlement to FTC
1 April 2009
Pfizer gets clarified Lipitor patent
12 January 2009
Court denies Hi-Tech Pharmacal
22 December 2008
US Court rules Plavix patent valid to 2011
22 December 2008
AstraZeneca axes jobs, closes plants
1 December 2008
Sanofi successfully defends Plavix patent in Canada
17 November 2008
TRIPs mechanism set to fail as Apotex ships ARV
29 September 2008
Apotex sued by Sanofi, settles with Pfizer
18 August 2008
Meda resolves patent suits against Apotex
28 April 2008
India patent battle over Tarceva opens new CL front
21 January 2008
Apotex buys Spain's Lareq Pharma
10 December 2007
Apotex buys Zambon generics unit
26 November 2007
Lilly/Daiichi Sankyo's prasugrel cuts CV AEs 19% vs Plavix, but side effects raise doubts
21 November 2007
Beijing Med-Pharm to market Ferriprox in China
29 October 2007
Canadian federal court upholds Viagra patent
8 October 2007
Canada issues WTO compulsory license for HIV/AIDS drug
8 October 2007
Neurontin ruling overturned by US court
1 October 2007
"Admonishment" for ApoPharma and AstraZeneca
17 September 2007
Barr's Portia approved and launched in Canada
3 September 2007
Canada's Health Minister slams generic prices
13 August 2007
Rwanda HIV/AIDS drug patent move
30 July 2007
US FDA approves generic Lamisil
9 July 2007
Update: Plavix cloud lifts over Sanofi/B-MS
25 June 2007
Sanofi/B-MS prevail over US Plavix patent
25 June 2007
B-MS pleads guilty in Plavix antitrust case
18 June 2007
Mylan wins generic omeprazole case
11 June 2007
B-MS resolves Plavix antitrust probe
21 May 2007
FDA disallows generic amlodipine other than Mylan's
23 April 2007
Sanofi-Aventis loses US Lovenox patent case
19 February 2007
Update: Rumors say Sanofi to merge with B-MS
5 February 2007
B-MS swings to loss in 4th qtr due to Plavix
5 February 2007
Rumors say Sanofi to merge with B-MS
5 February 2007
Canada: new formulary for new year - Ontario introducing reform
15 January 2007
Good patent news for Lilly, Pfizer and Sanofi-Aventis
8 January 2007
US Court upholds Sanofi and B-MS' injunction against Apotex
18 December 2006
Canada's generic drug firms greet court ruling
13 November 2006
Generics, including Plavix, and govt cost-cutting hit Sanofi-Aventis' 3rd-qtr results
6 November 2006
Apotex' denied motion to restart Plavix sales
2 October 2006
UPDATE: Bristol-Myers Quibb fires CEO Peter Dolan and general counsel Richard Willard
18 September 2006
Dolan ousted as B-MS CEO by board; Willard also goes
18 September 2006
Plavix gets EC nod for STEMI patients
18 September 2006
Apotex denied stay of Plavix injunction
11 September 2006
Stock Commentary - New York week to Sept 4, 2006
11 September 2006
B-MS cuts 2006 EPS to $0.95 after Plavix loss
11 September 2006
US Court stops Apotex' generic Plavix; Sanofi and B-MS shares rise despite no recall
11 September 2006
Stock Commentary - Europe - week to Aug 28, 2006
4 September 2006
Court deliberates Apotex' Plavix launch
28 August 2006
B-MS board could replace CEO?
28 August 2006
Update on Sanofi/B-MS Apotek injunction
28 August 2006
Stock Commentary - New York week to Aug 7, 2006
14 August 2006
Stock Commentary - New York week to Aug 7, 2006
7 August 2006
Stock Commentary - Europe - week to Aug 7, 2006
7 August 2006
Plavix deal fails to get US antitrust OK
7 August 2006
FDA pre-emption halts generic Plaxil trial
19 June 2006
Stock Commentary - New York week toJune 12, 2006
19 June 2006
Positive reading for Sanofi Plavix deal
29 May 2006
Stock Commentary - Europe - week to March 27, 2006
3 April 2006
Sanofi and B-MS settle with Apotex over Plavix
27 March 2006
Allergan reports strong 4th-qtr results
13 February 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
